Jimmy Akrivos1,2, Ramit Ravona-Springer3, James Schmeidler1, Derek LeRoith4,5, Anthony Heymann6, Rachel Preiss6, Hadas Hoffman6, Keren Koifman3, Jeremy M Silverman1,2, Michal Schnaider Beeri1,3,7. 1. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 2. James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA. 3. The Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel. 4. Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 5. Rambam Medical Center, Haifa, Israel. 6. Maccabi Healthcare Services, Tel Aviv, Israel. 7. Interdisciplinary Center (IDC) Herzliya, Herzliya, Israel.
Abstract
OBJECTIVE: Glycated hemoglobin (HbA1c) and C-reactive protein (CRP) have been associated with cognitive impairment independently. However, it is unclear if their combination exacerbates poor cognitive function. We assessed whether long-term glycemic level and glycemic variability modulate the association of systemic inflammation with cognitive function, in a sample of cognitively normal older people with type 2 diabetes. METHODS: A retrospective cohort study of 777 randomly selected participants from ~11,000 patients in the Maccabi Healthcare Services Diabetes Registry, as part of the Israel Diabetes and Cognitive Decline study. Subjects averaged 18 (±9.4) HbA1c measures in the Maccabi Healthcare Services Registry, which were used to calculate long-term glycemic level (HbA1c-mean) and glycemic variability (HbA1c-standard deviation (SD)). Linear regression models assessed the interactions of CRP, a marker of systemic inflammation, with HbA1c-mean and HbA1c-SD on subjects' performance in tests of Memory, Executive Functions, Attention, and Semantic Categorization. RESULTS: Quadratic interactions of CRP with HbA1c-SD approached significance for executive functions and overall cognition. However, after Bonferroni adjustment, none of the interactions of CRP with HbA1c were statistically significant. In partial correlations according to HbA1c-SD tertiles, CRP was weakly correlated in the middle tertile with decreased performance in the domains of semantic categorization (r = -0.166, p = 0.011), executive functions (r = -0.136, p = 0.038), and overall cognition (r = -0.157, p = 0.016). CONCLUSIONS: Glycated hemoglobin does not substantially modulate the association of CRP with cognition in a sample of cognitively normal, community dwelling older people with relatively well-managed type 2 diabetes.
OBJECTIVE: Glycated hemoglobin (HbA1c) and C-reactive protein (CRP) have been associated with cognitive impairment independently. However, it is unclear if their combination exacerbates poor cognitive function. We assessed whether long-term glycemic level and glycemic variability modulate the association of systemic inflammation with cognitive function, in a sample of cognitively normal older people with type 2 diabetes. METHODS: A retrospective cohort study of 777 randomly selected participants from ~11,000 patients in the Maccabi Healthcare Services Diabetes Registry, as part of the Israel Diabetes and Cognitive Decline study. Subjects averaged 18 (±9.4) HbA1c measures in the Maccabi Healthcare Services Registry, which were used to calculate long-term glycemic level (HbA1c-mean) and glycemic variability (HbA1c-standard deviation (SD)). Linear regression models assessed the interactions of CRP, a marker of systemic inflammation, with HbA1c-mean and HbA1c-SD on subjects' performance in tests of Memory, Executive Functions, Attention, and Semantic Categorization. RESULTS: Quadratic interactions of CRP with HbA1c-SD approached significance for executive functions and overall cognition. However, after Bonferroni adjustment, none of the interactions of CRP with HbA1c were statistically significant. In partial correlations according to HbA1c-SD tertiles, CRP was weakly correlated in the middle tertile with decreased performance in the domains of semantic categorization (r = -0.166, p = 0.011), executive functions (r = -0.136, p = 0.038), and overall cognition (r = -0.157, p = 0.016). CONCLUSIONS: Glycated hemoglobin does not substantially modulate the association of CRP with cognition in a sample of cognitively normal, community dwelling older people with relatively well-managed type 2 diabetes.
Authors: Angela L Jefferson; Joseph M Massaro; Alexa S Beiser; Sudha Seshadri; Martin G Larson; Philip A Wolf; Rhoda Au; Emelia J Benjamin Journal: Neuroepidemiology Date: 2011-07-13 Impact factor: 3.282
Authors: J A Luchsinger; W Palmas; J A Teresi; S Silver; J Kong; J P Eimicke; R S Weinstock; S Shea Journal: J Nutr Health Aging Date: 2011-06 Impact factor: 4.075
Authors: Yuan Zhong; Xiao Yan Zhang; Ya Miao; Jie Hua Zhu; Hong Yan; Bei Yun Wang; Jun Jin; Ting Jun Hu; Wei Ping Jia Journal: Biomed Environ Sci Date: 2012-02 Impact factor: 3.118
Authors: Nancy S Jenny; Benjamin French; Alice M Arnold; Elsa S Strotmeyer; Mary Cushman; Paulo H M Chaves; Jingzhong Ding; Linda P Fried; Stephen B Kritchevsky; Dena E Rifkin; Mark J Sarnak; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2012-02-24 Impact factor: 6.053
Authors: A M Abbatecola; M R Rizzo; M Barbieri; R Grella; A Arciello; M T Laieta; R Acampora; N Passariello; F Cacciapuoti; G Paolisso Journal: Neurology Date: 2006-07-25 Impact factor: 9.910
Authors: Rebecca K West; Ramit Ravona-Springer; James Schmeidler; Derek Leroith; Keren Koifman; Elizabeth Guerrero-Berroa; Rachel Preiss; Hadas Hoffman; Jeremy M Silverman; Anthony Heymann; Michal Schnaider-Beeri Journal: Am J Geriatr Psychiatry Date: 2014-01-23 Impact factor: 4.105
Authors: Bernard Zinman; Steven P Marso; Neil R Poulter; Scott S Emerson; Thomas R Pieber; Richard E Pratley; Martin Lange; Kirstine Brown-Frandsen; Alan Moses; Ann Marie Ocampo Francisco; Jesper Barner Lekdorf; Kajsa Kvist; John B Buse Journal: Diabetologia Date: 2017-09-15 Impact factor: 10.122
Authors: Sharen Lee; Jiandong Zhou; Wing Tak Wong; Tong Liu; William K K Wu; Ian Chi Kei Wong; Qingpeng Zhang; Gary Tse Journal: BMC Endocr Disord Date: 2021-05-04 Impact factor: 2.763